Introduction {#S5}
============

The cerebral vascular autoregulatory system is a physiologic mechanism that maintains consistent and stable cerebral blood flow (CBF). It works, in part, by attenuating the effect of low frequency oscillations in blood pressure by way of a high-pass filter ([@R1],[@R2]). In the mid-19^th^ century, Siegmund Mayer noted spontaneous rhythmic oscillations in blood pressure, with a period of approximately 10 seconds (0.1 Hz). Later experimental evidence demonstrated that these oscillations, now called "Mayer waves," arise as the result of oscillations in the sympathetic vasomotor tone of arterial blood vessels throughout the body ([@R3]), coordinated via cytosolic signaling and leading to synchronized activation of smooth muscle cells ([@R4]). Dysfunction of the cerebral autoregulatory system, and therefore loss of dampening of blood flow oscillations, leads to unstable CBF as demonstrated by Ocon et al., who found strong transmission of 0.1 Hz oscillations in blood pressure to the cerebral vasculature (indicative of a loss in dampening) with an associated reduction in cerebral blood flow velocity in a series of patients with dysautonomia ([@R5]).

Recent approaches to quantifying cerebral autoregulation have focused on the relationship between the mean arterial blood pressure (MAP) and cerebral saturation measured by near-infrared spectroscopy (NIRS). Reliably testing the function of the cerebral autoregulatory system in the preterm population, however, has proven to be a difficult task, largely due to the broad diversity in neurophysiologic development, technical challenges associated with capturing data, the lack of a clear definition for hypotension ([@R6]) and lack of a standardized analysis methodology. A variety of methods have been used including low frequency coherence ([@R7],[@R8]) and time-domain correlation ([@R9],[@R10]) with findings consistent with those of the older, more invasive approaches i.e., that sick, preterm infants have more evidence of autoregulatory dysfunction ([@R11],[@R12]). While individually interesting, drawing larger conclusions from these studies has been very difficult due to a lack of a standardized approach to collecting data (e.g. sampling rates ranging 0.2-10 Hz) and interpretation of results. Furthermore, these approaches fundamentally examine the statistical correlation between the MAP and the cerebral NIRS signal, inherently requiring an arbitrary threshold value and thereby converting a dynamic process to a binary one.

An alternate view of autoregulatory systems can be derived by repeatedly measuring how naturally occurring oscillations are transformed and reflected in the cerebral circulation. We hypothesize that impaired autoregulation will manifest as a loss of dampening, i.e. a greater amplitude of systemic blood pressure oscillations transmitted to the cerebral circulation. An approach to measure this dampening effect, termed transfer function analysis, has been used to evaluate cerebral autoregulation in healthy adults ([@R13]) and adults with autonomic failure ([@R14]). The strength of this approach is that it measures dampening on a continuum that may evolve across gestational age, medical illness or time.

In this study, we investigated the dampening ability of the cerebral autoregulatory system in preterm infants during the first 72 hours of life using transfer function analysis. We hypothesized that (i) advancing gestational age would be associated with improved dampening ability, (ii) perinatal factors would modulate dampening ability, and (iii) IVH would be associated with decreased dampening.

Results {#S6}
=======

Sample characteristics and data quality {#S7}
---------------------------------------

Sixty-two infants were prospectively recruited for the study with a mean gestational age 25.4 ± 1.3 weeks, mean birth weight 833 ± 199 grams, and 42/62 (67%) were male. A comprehensive list of sample characteristics can be found in [Table 1](#T1){ref-type="table"}.

The median postnatal age at recording start was 12 hours (range 5-24 hours) and a median of 204 twenty-minute data epochs (approximately 68 hours) were captured per infant. Preprocessing resulted in average rejection of 49% of collected data epochs leaving amedian of 105 data epochs (range 48-348 data epochs) per infant in the final analysis. 61% of rejected data epochs occurred due to motion artifact, 35% of rejected epochs occurred due to desaturation, while the remaining 4% of epochs were rejected due to interruptions in the recording.

In [Figure 1](#F1){ref-type="fig"}, the dampening curve for an example infant is shown after ensemble averaging of 50, 150 and 300 data epochs respectively. The shape of the curve is consistent, with a "notch" at approximately 0.1 Hz (Mayer wave frequency) with an increasing degree of smoothness as more data epochs are incorporated in the ensemble average. The bottom panel of [Figure 1](#F1){ref-type="fig"} depicts the estimate of dampening at the Mayer wave frequency for the same infant as an increasing number of data epochs are averaged, demonstrating that the estimate stabilizes after averaging a minimum of 25 data epochs (approximately 8 hours), varying by no more than 0.5 dB.

The dampening curve and gestational age {#S8}
---------------------------------------

The mean dampening curve, grouped by gestational age, is shown in [Figure 2](#F2){ref-type="fig"} and demonstrates a remarkably similar shape, regardless of the gestational age of the infant, with a developmental trend noted across gestational age clusters with increasing degrees of dampening (more negative) with advancing maturity at birth.

Multiple linear regression model {#S9}
--------------------------------

The multiple linear regression prediction model was statistically significant (*F*(7, 54)=9.26, *p*\< 0.01) and accounted for approximately 50% of the variance (*R*^2^=0.546, Adjusted *R*^2^=0.487). Advancing EGA at birth, chorioamnionitis, and birthweight z-scores were independently associated with greater dampening. African-American race and diagnosis of IVH at any time during the first week of life (of any grade) were independently associated with less dampening. The complete model output is shown in [Table 2](#T2){ref-type="table"}.

IVH {#S10}
---

In the overall group, 23/62 infants (37%) had IVH of any grade while 6/23 (26%) had severe (grade III or IV) IVH. Given the initial results demonstrating a link between decreased dampening and IVH, a second level of analysis was conducted to investigate the dampening ability of infants who had IVH during the first three days (and thus had contemporaneous measurement of dampening ability). We restricted the analysis of dampening to those infants (15/23) where there was certainty about the IVH status during the monitoring period. For the remaining 8/23 infants with IVH, the diagnosis was made outside of the monitoring window. In 3/8 of these infants there was no IVH noted on the initial ultrasound performed on the first day of life but follow-up imaging was not performed until seven days of life or later. The other five infants did not have any imaging performed until one week of life. In either case, it is impossible to determine if the hemorrhage occurred during the data acquisition period, thus the reason for exclusion. A statistical comparison of these infant groups is provided in [Table 3](#T3){ref-type="table"}.

Frequency response curves were clustered by IVH status as shown in [Figure 3](#F3){ref-type="fig"}. Visual inspection demonstrated a clear gap in the dampening ability between the groups across the entire frequency band, including the Mayer wave frequency. The binary logistic regression prediction model was statistically significant (*χ^2^* = 24.57, *p* \< 0.01) and accounted for approximately 30% of the variance (*R*^2^=0.385, Adjusted *R*^2^=0.275). Higher birth weight z-score was independently associated with a lower likelihood of developing IVH, while decreased dampening and fentanyl exposure were associated with a greater likelihood of developing IVH. Complete model output is shown in [Table 4](#T4){ref-type="table"}. A separate analysis for infants with high grade IVH was not possible due to the small number of infants in this category (n=4).

Discussion {#S11}
==========

In this study, we have demonstrated the feasibility of measuring cerebral autoregulation in preterm infants using NIRS and arterial blood pressure data collected continuously over the first three days of life. These data demonstrate evidence for dampening of spontaneous oscillations in systemic blood pressure by the cerebral autoregulatory system, particularly prominent at the Mayer wave frequency. Furthermore, this dampening ability increased as a function of advancing gestational age at birth and was decreased in infants who developed IVH. Our data build on findings of Rhee et al. ([@R15]), that there is ongoing development of the cerebral autoregulatory system during the second trimester. This is not surprising, given that simultaneous maturation of other organ systems occurs over the same period. The functional effect of the maturation is quite profound: the difference in dampening ability of the cerebral circulation between those born at 24 and 28 weeks (6 dB) represents a 600% increase.

The mechanism underlying IVH is undoubtedly complex and multifactorial. Impaired autoregulation and resulting ischemia-reperfusion has been proposed as a contributing factor for the development of IVH in the past ([@R16]), a postulation which is somewhat borne out by our data. Nevertheless, the logistic regression model (of which dampening was a part) only explained about 30% of the variance predicting risk for IVH. Our findings are best interpreted in the context of vulnerability: impaired autoregulation does not equate to brain injury in every infant, but rather a diminishing ability to cope with perturbations in systemic perfusion that are common during this transitional period.

Our IVH data provide additional context for this vulnerability: those infants who develop IVH had a statistically worse ability to dampen systemic blood flow fluctuations, even when holding other clinical factors constant. A similar pattern of decreased dampening after brain injury has previously been described in adults with intracranial hemorrhage ([@R17]) or head trauma ([@R18]), with less dampening noted in those with more elevated intracranial pressures despite using a completely different technique for measurement of CBF (transcranial Doppler ultrasound). Caution should be urged in interpretation of these data. Due to the "snapshot" nature of CUS and the inability to precisely determine when IVH occurred, this methodology cannot distinguish between decreased dampening as an antecedent or sequela of IVH.

Given that the overarching objective was to develop a robust model of cerebral autoregulation, careful monitoring of data quality was of the utmost importance. The NICU is a noisy environment, and extracting a valid signal is challenging. We set strict criteria for data exclusion and did not interpolate missing data in order to reduce the likelihood of introducing error. The use of ensemble averaging allowed even further noise reduction, as graphically demonstrated in [Figure 1](#F1){ref-type="fig"}. Despite the strict criteria, a clear view of autoregulatory system was indeed possible with as few as 25 data epochs (or about 8 hours of data).

There is however, a potential bias introduced by rejection of such a significant quantity of data. This study methodology examines the relationship between blood pressure and cerebral oximetry in the frequency domain. Interpolation of a discontinuous time-series introduces error into the frequency domain representation of the data, becoming particularly prominent when the length of the discontinuity approaches the frequency of interest, in this case 0.1 Hz or 10 seconds (also known as the Gibbs phenomenon). Knowingly introducing error by interpolation was viewed to be an inferior choice in comparison to an, albeit unknown, possibility of bias due to exclusion. Future studies, with greater tolerance of noise or error may be able to derive the autoregulatory curve with even less data.

Although interpreted with great caution given the exploratory nature of the project, it is interesting to note the perinatal characteristics that were associated with improved dampening, namely chorioamnionitis and a higher birthweight z-score, perhaps as the result of more advanced physiologic maturation. Chorioamnionitis, in particular, has long been associated with rapid pulmonary maturation, the so-called "Watterberg effect" ([@R19]) and one could postulate that this systemic inflammation may induce extrapulmonary maturational changes. Similarly, higher birth weight z-score is associated with a greater likelihood of survival, largely attributable to more mature organ functioning.

Given these findings, it was surprising to find no association between antenatal corticosteroids and improved cerebrovascular autoregulation, particularly given prior association with improved function of the sympathetic nervous system in preterm infants ([@R20]). However, there was significant heterogeneity in the number of steroid doses received prior to birth, with less than half of the infants receiving a full course prior to birth, potentially confounding this effect.

Although racial differences in autoregulatory function have not been previously described, a recent paper by Shankaran et al. describes racially-based differences in the risk for IVH ([@R21]), with a reduced risk for IVH in Caucasian infants and no difference between male and female infants, possibly attributable to genetic factors as well as access prenatal care.

Future studies should evaluate the autoregulatory curve in a larger cohort, in particular one powered to assess the impact of antenatal steroids. A more rigorous CUS schedule will allow for a better estimate of IVH timing and allow for a more granular analysis of the dampening characteristics before, during and after hemorrhage.

A more complete understanding of the cerebral autroregulatory system will greatly benefit clinicians seeking to improve the care of preterm infants. Translation of this analysis method to real-time monitoring will enable clinicians to better implement neuroprotection strategies in this vulnerable population.

Methods {#S12}
=======

Participants {#S13}
------------

Preterm infants, born prior to 28 completed weeks of gestation, were recruited as close to birth as possible for a prospective monitoring study during the first 72 hours of life. The Washington University School of Medicine Human Research Protection Office approved the study and informed consent was obtained from the parents prior to data collection. Infants were only excluded if there was an antenatal diagnosis of a congenital malformation or if the clinical team did not elect to place an umbilical artery catheter. Historical data from our NICU indicated that more than 90% of infants meeting these criteria had an umbilical arterial line placed, making this an unlikely source of bias.

Maternal and Infant Clinical Characteristics {#S14}
--------------------------------------------

Perinatal factors were collected including prenatal visits and antenatal steroid or magnesium sulfate administration. Infant clinical characteristics were also collected from the infant\'s medical record including birth weight, birth weight z-score (calculated from the Fenton growth charts ([@R22])), sex, race, dopamine or fentanyl administration, and cranial ultrasound reports.

Physiologic data collection {#S15}
---------------------------

### NIRS {#S16}

Cerebral tissue oxygen saturation (SctO~2~) was obtained using 4-wavelength (690nm, 780nm, 805nm and 850nm) near-infrared spectroscopy (Foresight, CAS Medical Systems, Inc., Branford, CT) with a transducer containing a fiber-optic emitter and one detector located 25 mm from the light source. The non-adhesive optode was placed on the frontoparietal scalp, and recording was conducted over the first 72 hours after birth. As maintaining skin integrity in this vulnerable patient population was a high priority, a plan was developed prior to initiation of the study to limit the length of individual recordings to no more than 12 hours (thus providing a "rest period") before repositioning the sensor approximately 1cm laterally so as to prevent skin breakdown.

Regional cerebral tissue oxygen saturation measurements have previously been used to study autoregulation in preterm infants ([@R23]) and are less affected by motion artifact when compared to hemoglobin difference (HbD), a different NIRS-derived oximetry measurement which measures the difference in concentrations between oxy- and deoxyhemoglobin. ([@R24]).

This study, as is the case for all cerebrovascular research using NIRS technology, is limited, to an extent, by the nature of the measurement, a regional mixed-venous saturation rather than a direct measurement of CBF itself. Nevertheless, there is agreement between NIRS and non-NIRS derived measures of CBF, allowing NIRS to play an important role in continuous cerebral hemodynamic monitoring in patients who can not be easily transported (i.e. very preterm infants). For example, Roche-Labarbe et al. demonstrated a modest correlation (r=0.22) between NIRS and transcranial Doppler ultrasound measures of CBF in very preterm infants ([@R25]), Kim et al. noted a relatively strong correlation (r=0.73) between NIRS and xenon-enhanced CT imaging estimates of CBF in adult stroke patients ([@R26]), and Wintermark et al. demonstrated an even stronger relationship (r=0.88) between NIRS and MRI based estimates of CBF in term infants with severe encephalopathy ([@R27]).

### Mean Arterial Blood Pressure (MAP) {#S17}

The MAP was obtained from an umbilical arterial line (Argyle polyurethane umbilical vessel catheter, Covidien, Mansfield, MA) connected to a digital pressure transducer on the patient monitor (Intellivue MP70, Phillips Medical, Andover, MA).

### Imaging {#S18}

Cranial ultrasound (CUS) examinations were performed in the first week of life, per the discretion of the clinical team. Intraventricular hemorrhage was graded on a scale from 0-4 by radiologists blinded to the study data ([@R28]). Results of CUS exams performed outside of monitoring period were also captured to assess for later development of IVH.

### Data collection {#S19}

Both NIRS and MAP data streams were captured simultaneously on a laptop computer using custom data acquisition software (CAS Medical Systems, Inc., Branford, CT) in a time-synchronized fashion at a sampling rate of 0.5 Hz. Any interruptions in recording, such as "rest periods", withdrawal of blood through the catheter for laboratory testing, or infusion through the line, were noted by the bedside nurse or research assistant. The resulting data file was exported for offline analysis. Study data were collected and managed using REDCap electronic data capture tools ([@R29]) hosted at Washington University.

Pre-processing {#S20}
--------------

The NIRS and MAP data streams were extracted from the source data file. Both data streams underwent multistep pre-processing to eliminate missing or invalid data. Twenty minutes (600 serial, non-overlapping samples) of data were loaded at a time and inspected for (i) interrupted regions of the recording (as indicated in the research record), (ii) regions of the recording flagged by the NIRS device where it was not able properly measure the SctO~2~ (e.g. probe not in good contact with the skin), (iii) regions with sudden, non-physiologic changes in the baseline or excessive variance, based on the sliding-window motion artifact rejection algorithm proposed by Ayaz et al.([@R30]), and (iv) regions of the trace where systemic saturation was below the lower limit of our target saturation guidelines (SpO~2~ \<85%) given evidence that hypoxemia causes deviation from the expected arterial-venous contributions to the SctO~2~, making data during this time period unreliable ([@R31]). The entire data epoch was rejected if it failed at any one of these checks.

Transfer function analysis {#S21}
--------------------------

The transfer function gain coefficient (dampening) was estimated for each remaining, error-free epoch using the equation: $H{(f)} = \frac{G_{io}(f)}{G_{ii}(f)}$ where *G~io~*(*f*) represents the cross-power spectrum between the input (MAP) and the output (SctO~2~) and *G~ii~*(*f*) represents the auto-power spectrum of the input (MAP). Welch\'s modified periodogram method was used for spectral calculation. This calculation was made by first dividing each 20-minute epoch, which is composed of 600 individual samples, into five segments overlapped by 75%. The modified periodgram is computed for each segment and the results are averaged to provide a more accurate estimate of the spectral density. A Blackmann-Harris window was applied to the time-domain signal prior to spectral estimation to reduce spectral leakage.

The transfer function estimate was then calculated from 0.0 to 0.25 Hz, limited by the Nyquist theorem given the sampling rate of 0.5 Hz, yielding a frequency resolution of 0.0009 Hz. Noise reduction was accomplished by ensemble averaging of the frequency response curve of each epoch within subjects and then between subjects, clustered by gestational age. The gain coefficient was logarithmically transformed to provide the amplitude of the dampening response measured in decibels (dB) where 0 dB represents no transformation and -10 dB represents a 10-fold reduction in oscillation power. The mean gain coefficient in the Mayer wave frequency band (defined as 0.08-0.12 Hz) was calculated for each infant.

All signal processing was conducted using an in-house software package developed for MATLAB 8.4 (The MathWorks, Inc., Natick, MA).

Statistical analysis {#S22}
--------------------

Covariate selection for the multiple linear regression model was undertaken by combining biologically plausible factors (gestational age, birth weight z-score, antenatal steroid exposure) with important perinatal factors identified by forward stepwise multiple linear regression in order to develop a comprehensive, yet parsimonious model and avoid overfitting. Correlation between predictors was assessed using the variance inflation factor (VIF), a measure of the degree of multicollinearity where VIF \> 5 is indicative of highly correlated predictors.

A between-groups comparison was made for those with and without IVH by use of the Mann-Whitney U-test for continuous variables and a two-sided Fisher\'s Exact test for categorical variables. The influence of dampening on the outcome of IVH was assessed using binary logistic regression with covariate selection undertaken in the same fashion as in the previous step.

Statistical analysis including descriptive statistics and regression modeling were conducted using R version 3.1.0 (R Project for Statistical Computing, Vienna, Austria) and Minitab 17.0 (Minitab Inc., State College, PA).
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![Data quality example. The dampening curve for a single subject is shown after ensemble averaging of (A) 50, (B) 150, and (C) 300 data epochs respectively. The estimate of the dampening ability as the number of samples in the ensemble average is increased is shown in (D).](nihms723691f1){#F1}

![Dampening ability by gestational age. Broadband frequency response of the autoregulatory system by gestational age at birth. The response (dampening) of the autoregulatory system is indicated on the Y-axis for discrete frequencies between 0 and 0.25 Hz. Note the increased dampening at approximately 0.1 Hz (Mayer frequency band). Infants are grouped by gestational and color coded (red-24 weeks (n=17), yellow-25 weeks (n=15), purple-26 weeks (n=19), green-27 weeks (n=5), blue-28 weeks (n=6)).](nihms723691f2){#F2}

![Magnitude of dampening vs. frequency for infants with IVH (solid line) and without IVH (dashed line).](nihms723691f3){#F3}

###### Descriptive statistics of sample

                                                                   Sample (n=62)
  ---------------------------------------------------------------- ---------------
  Gestational age at birth, *mean* ± *SD*, weeks                   25.4 ± 1.3
  Birth weight, *mean* ± *SD*, grams                               833 ± 199
  Male sex, *n* (%)                                                42 (67)
  Race                                                             
   White, *n* (%)                                                  32 (52)
   African-American, *n* (%)                                       30 (48)
  SGA, *n* (%)                                                     5 (8)
  Antenatal steroids                                               
   None, *n* (%)                                                   15 (24)
   Partial course, *n* (%)                                         19 (31)
   Complete course, *n* (%)                                        28 (45)
  Chorioamnionitis[b](#TFN2){ref-type="table-fn"}, *n* (%)         22 (35)
  Antenatal magnesium sulfate exposure, *n* (%)                    28 (45)
  Adequate prenatal care[a](#TFN1){ref-type="table-fn"}, *n* (%)   46 (74)
  Vaginal delivery, *n* (%)                                        25 (40)
  Delayed cord clamping, *n* (%)                                   9 (15)
  Mechanical ventilation at 72h, *n* (%)                           45 (73)
  Dopamineexposure, *n* (%)                                        17 (27)
  Fentanylexposure, *n* (%)                                        22 (35)
  IVH                                                              
   All grades, *n* (%)                                             23 (39)
   Grade III-IV, *n* (%)                                           6 (10)
  Died in the neonatal period, *n* (%)                             6 (10)

Defined as receiving at least 75% of expected visits at time of birth ([@R27],[@R28]).

Based on histologic examination of the placenta.

###### Multiple regression model for predictors of dampening in the Mayer wave frequency band

  Factor                                            *β* Coefficient[a](#TFN4){ref-type="table-fn"}   P-value   VIF                                      
  ------------------------------------------------- ------------------------------------------------ --------- ---------------------------------------- ------
  BW z-score                                        -0.04                                            -0.26     0.01[\*](#TFN3){ref-type="table-fn"}     1.07
  EGA                                               -1.43                                            -0.48     \<0.01[\*](#TFN3){ref-type="table-fn"}   1.07
  African-American race                             2.26                                             0.29      \<0.01[\*](#TFN3){ref-type="table-fn"}   1.05
  Prenatal care                                     -1.33                                            -0.15     0.13                                     1.09
  IVH of any grade                                  2.55                                             0.31      \<0.01[\*](#TFN3){ref-type="table-fn"}   1.16
  Antenatal steroids                                0.72                                             0.08      0.433                                    1.18
  Chorioamnionitis[b](#TFN5){ref-type="table-fn"}   -1.10                                            -0.23     0.02[\*](#TFN3){ref-type="table-fn"}     1.10

denotes significance at p ≤ 0.05. Model R^2^ = 0.546, Adj. R^2^=0.487, p\<0.01.

VIF-Variance inflation factor.

Increase or decrease in magnitude of dampening from the mean (dB).

Based on histologic examination of the placenta.

###### Clinical characteristics by IVH status

                                                                                            IVH (n=15)      No IVH (n=39)   P-value
  ----------------------------------------------------------------------------------------- --------------- --------------- ---------
  Gestational age, *mean* ± *SD*, weeks[a](#TFN7){ref-type="table-fn"}                      25.1 (1.4)      25.6 (1.4)      0.288
  Birth weight, *mean* ± *SD*, grams[a](#TFN7){ref-type="table-fn"}                         876.7 (228.5)   823.2 (197.5)   0.475
  Male sex, *n* (%)[b](#TFN8){ref-type="table-fn"}                                          11 (73)         25 (64)         0.748
  African-American race, *n* (%)[b](#TFN8){ref-type="table-fn"}                             8 (53)          18 (46)         0.764
  SGA, *n* (%)[b](#TFN8){ref-type="table-fn"}                                               1 (7)           4 (10)          1.00
  Antenatal steroids, *n* (%)[b](#TFN8){ref-type="table-fn"}                                9 (60)          33 (85)         0.071
  Antenatal MgSO4, *n* (%)[b](#TFN8){ref-type="table-fn"}                                   6 (40)          22 (56)         0.366
  Chorioamnionitis[c](#TFN9){ref-type="table-fn"}, *n* (%)[b](#TFN8){ref-type="table-fn"}   6 (40)          12 (31)         0.536
  Adequate prenatal care[d](#TFN10){ref-type="table-fn"}, *n* (%)                           10 (67)         30 (77)         0.498
  Vaginal delivery, *n* (%)                                                                 9 (60)          13 (33)         0.121
  Delayed cord clamping, *n* (%)[b](#TFN8){ref-type="table-fn"}                             3 (20)          4 (10)          0.382
  Mech. ventilation at 72 hours, *n* (%)[b](#TFN8){ref-type="table-fn"}                     13 (87)         24 (62)         0.105
  Dopamine exposure, *n* (%)[b](#TFN8){ref-type="table-fn"}                                 5 (33)          10 (26)         0.735
  Fentanyl exposure, *n* (%)[b](#TFN8){ref-type="table-fn"}                                 8 (53)          10 (25)         0.105
  Died in the neonatal period, *n* (%)[b](#TFN8){ref-type="table-fn"}                       0 (0)           4 (10)          0.567

denotes significance at p ≤ 0.05. Comparison made using

Mann-Whitney U test or

Fisher\'s Exact Test (two-sided).

Based on histologic examination of the placenta.

Defined as receiving at least 75% of expected visits at time of birth ([@R27],[@R28]).

###### Binary logistic regression model for predictors of IVH, all grades

  Factor                                             *β* Coefficient[a](#TFN12){ref-type="table-fn"}   P-value   VIF                                       
  -------------------------------------------------- ------------------------------------------------- --------- ----------------------------------------- ------
  BW z-score                                         -0.04                                             2.62      0.01[\*](#TFN11){ref-type="table-fn"}     1.50
  Dampening                                          0.34                                              2.96      \<0.01[\*](#TFN11){ref-type="table-fn"}   2.07
  EGA                                                0.38                                              1.16      0.37                                      1.81
  Vaginal delivery                                   1.39                                              1.53      0.11                                      1.22
  Antenatal steroids                                 -1.84                                             -1.71     0.07                                      1.22
  Chorioamnionitis[b](#TFN13){ref-type="table-fn"}   1.27                                              1.34      0.16                                      1.30
  Fentanyl exposure                                  2.47                                              2.60      \<0.01[\*](#TFN11){ref-type="table-fn"}   1.43

denotes significance at p ≤ 0.05. Model R^2^ = 0.39, Adj. R^2^=0.28, p\<0.01.

VIF-Variance inflation factor.

Increase or decrease in magnitude of dampening from the mean (dB).

Based on histologic examination of the placenta.
